IRIS
CIMADAMORE, Alessia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 430
EU - Europa 364
AS - Asia 175
AF - Africa 73
SA - Sud America 8
OC - Oceania 1
Totale 1.051
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 425
IT - Italia 161
RU - Federazione Russa 136
SG - Singapore 85
TG - Togo 67
IN - India 30
CN - Cina 19
DE - Germania 12
GB - Regno Unito 12
NL - Olanda 12
TR - Turchia 10
HK - Hong Kong 9
IE - Irlanda 9
FI - Finlandia 8
IQ - Iraq 7
BR - Brasile 6
CA - Canada 5
BD - Bangladesh 4
LT - Lituania 4
GR - Grecia 3
IR - Iran 3
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
JP - Giappone 2
KW - Kuwait 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
LV - Lettonia 1
SA - Arabia Saudita 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 1.051
Salva come PNG Salva come JPEG
Città #
Boardman 198
Lomé 67
Ogden 59
Singapore 55
Milan 24
Rome 19
Hyderabad 16
Ashburn 14
Codroipo 13
Frankfurt am Main 10
Dublin 9
Naples 7
Amsterdam 6
Hong Kong 6
New York 6
Orta Nova 6
Balıkesir 5
Lappeenranta 5
São Paulo 5
Bengaluru 4
Karbala 4
Porcia 4
Xi'an 4
Al Hillah 3
Helsinki 3
London 3
Secaucus 3
Shanghai 3
Trabzon 3
Aligarh 2
Ancona 2
Athens 2
Bari 2
Bhubaneswar 2
Cagliari 2
Castiglione delle Stiviere 2
Cavaso del Tomba 2
Dongguan 2
Foggia 2
Frosinone 2
Giza 2
Greenwood 2
Groningen 2
Isfahan 2
Islamabad 2
Istanbul 2
Kolkata 2
Kuwait City 2
Los Angeles 2
Madrid 2
Magliano in Toscana 2
Meldola 2
Mount Pearl 2
Ottawa 2
Oude Meer 2
Padova 2
Perugia 2
Santa Clara 2
Scandicci 2
Seattle 2
Silver Spring 2
Slough 2
St Petersburg 2
Thiruvananthapuram 2
Triggiano 2
Verona 2
Wauwatosa 2
West Jordan 2
Beijing 1
Camerino 1
Carpenedolo 1
Changteh 1
Chapel Hill 1
Dallas 1
Delhi 1
Dhaka 1
Fontebuona 1
Gatchina 1
General Rodriguez 1
Glenwood 1
Guangzhou 1
Houston 1
Jeddah 1
Liberec 1
Limena 1
Miami 1
Nauen 1
Niterói 1
Olomouc 1
Otemachi 1
Penalolen 1
Riga 1
Ronchi dei Legionari 1
Shiraz 1
Siena 1
Srimangal 1
Temecula 1
The Dalles 1
Toronto 1
Treviolo 1
Totale 674
Salva come PNG Salva come JPEG
Nome #
News in the classification of WHO 2022 bladder tumors 84
SIUrO best practice recommendations to optimize BRCA 1/2 gene testing from DNA extracted from bone biopsy in mCRPC patients (BRCA Optimal Bone Biopsy Procedure: BOP) 41
Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysis 34
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 24
Histopathology of Prostate Cancer and its Precursors 23
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer 20
How To Report the Minor Component of a High-grade Pattern in Radical Prostatectomy Specimens: Time To Abandon the “Tertiary” Terminology? 19
Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis 19
Digital real-time microscopy of ex-vivo tissues: A novel strategy to control surgical accuracy 18
Follow-up of the Urethra and Management of Urethral Recurrence After Radical Cystectomy: A Systematic Review and Proposal of Management Algorithm by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group 17
A gender-related dichotomy in bladder cancer 15
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 14
OUTCOMES OF DIFFERENT PATTERN OF SEMINAL VESICLE INVASION IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY 14
Frequent Telomerase Reverse Transcriptase Promoter and Fibroblast Growth Factor Receptor 3 Mutations Support the Precursor Nature of Papillary Urothelial Hyperplasia of the Urinary Bladder 14
PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What’s Now, What’s New, and What’s Coming? 14
Digital Frozen Sections with Fluorescence Confocal Microscopy During Robot-assisted Radical Prostatectomy: Surgical Technique 14
Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial 13
The pathway of isolated seminal vesicle invasion has a different impact on biochemical recurrence after radical prostatectomy and pelvic lymphadenectomy 13
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies 13
Tumors of the Urinary System and Male Genital Organs: 2022 World Health Organization Classification and Multidisciplinarity 12
Predictive and prognostic biomarkers in urological tumours 12
An insight on novel molecular pathways in metastatic prostate cancer: A focus on ddr, msi and akt 12
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysis 11
Giant cell carcinoma of the urinary bladder: Clinicopathologic analysis and oncological outcomes 11
The most effective but largely ignored target for prostate cancer early detection and intervention 11
An update on investigational therapies that target STAT3 for the treatment of cancer 11
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 11
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis 11
Biphasic Tumors of the Urogenital Tract: Selected Topics 11
T1 bladder carcinoma with variant histology: pathological features and clinical significance 11
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B) 11
Re: Timothy D. Jones, Liang Cheng. Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups. Eur Urol 2021;79:489–91 10
Are liver nested stromal epithelial tumors always low aggressive? 10
Morphologic spectrum of the epithelial tumors of the male and female urethra 10
Re: Human Chimeric Antigen Receptor Macrophages for Cancer Immunotherapy 10
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer 10
Re: George J. Netto, Mahul B. Amin, Eva M. Compérat, et al. Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.015 10
Re: Martha Boone. The Unfettered Urologist. What I Never Had Time to Tell You in a Fifteen Minute Office Visit. New York, NY: Morgan James Publishing; 2023 10
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature 10
Myoid gonadal stromal tumours are characterised by recurrent chromosome-level copy number gains: molecular assessment of a multi-institutional series 10
Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications 10
Re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019;75:667–75: How Does Circulating DNA Reach the Blood Stream? 10
Pathology of the benign and malignant diseases of the prostate 10
Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators 10
Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward 10
Spectrum of incipient (or precursor) lesions in the mucosa of the seminal vesicles 10
Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype 10
From undergraduate medical school student to visible pathologist 9
Conceptual Analogies Between Multi-Scale Feeding and Feedback Cycles in Supermassive Black Hole and Cancer Environments 9
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets 9
Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer 9
Predicting future cancer burden in the United States by artificial neural networks 9
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 9
An update on immunotherapy in uro-oncology 9
Surgical pathology of cystic renal cell carcinomas: is there an overestimation of malignancy? 9
Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF? 9
Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives 8
Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers 8
Clinicopathologic analysis of upper urinary tract carcinoma with variant histology 8
The Prostatic Utricle and Endometrioid Prostate Cancer: Similarities, Differences and Challenges 8
RAS genes in colorectal carcinoma: Pathogenesis, testing guidelines and treatment implications 8
TNM staging towards a personalized approach in metastatic urothelial carcinoma: What will the future be like?-a narrative review 8
Grading of Chromophobe Renal Cell Carcinoma: Do We Need It? 8
Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View 8
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy? 8
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma 8
Pd-l1 inhibitors for the treatment of prostate cancer 8
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 8
Epigenetic modulations and lineage plasticity in advanced prostate cancer 8
Agent-Based Learning Model for the Obesity Paradox in RCC 8
Staging and reporting of renal cell carcinomas 8
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A) 8
Macro-microscopic evaluation of pathology specimens with large format histology. for the benefit of 'our service users and patients ' 8
Immunotherapy in genitourinary cancers: Where are we going? 7
Correlation between high pd-l1 and emt/invasive genes expression and reduced recurrence-free survival in blood-circulating tumor cells from patients with non-muscle-invasive bladder cancer 7
Molecular diagnostics in uro-oncology 7
Patients ask and pathologists answer: ten questions around prostate cancer grading 7
Digital frozen section of the prostate surface during radical prostatectomy: a novel approach to evaluate surgical margins 7
Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma 7
Liquid biopsy in the clinical management of bladder cancer: current status and future developments 7
Hot topics in renal cancer pathology: implications for clinical management 7
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution 7
Narrative review: Predicting future molecular and clinical profiles of prostate cancer in the United States 7
Designing novel immunocombinations in metastatic renal cell carcinoma 7
Re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.009: Focus on Intraductal Carcinoma of the Prostate 7
Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype 7
Immunotherapy for urothelial cancer: from the diagnostic pathologist’s point of view 7
Extramammary Paget disease of the penis closely mimicking the penile analogue of stratified mucin-producing intraepithelial lesion 7
Chromophobe Renal Cell Carcinoma Aggressiveness and Immuno-oncology Therapy: How to Distinguish the Good One from the Bad One 7
Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity 7
Prostate cancer in 2021: Novelties in prognostic and therapeutic biomarker evaluation 7
The molecular characteristics of non‐clear cell renal cell carcinoma: What’s the story morning glory? 7
Update on circulating tumor cells in genitourinary tumors with focus on prostate cancer 7
Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma 7
The 1996 European Urology Focus on Preneoplastic Lesions of the Prostate 7
Exploring the Spectrum of Kidney Ciliopathies 7
Metabolomic profiling in renal cell carcinoma patients: News and views 7
Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor? 7
The role of obesity in renal cell carcinoma patients: Clinical-pathological implications 7
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer 7
Totale 1.124
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.278
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023628 0 0 0 0 0 0 1 2 512 9 60 44
2023/2024411 25 9 17 10 36 24 10 22 88 112 29 29
2024/2025612 74 226 38 51 63 160 0 0 0 0 0 0
Totale 1.651